chloroxoquinoline

antineoplastic; structure in first source

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

1.	Stomach Neoplasms (Stomach Cancer) 03/01/2009 - "Chloroxoquinoline in combination with epirubicin, cisplatin and 5-fluorouracil in metastatic gastric cancer." 03/01/2009 - "The aim of this study was to evaluate the efficacy and tolerability of combination chemotherapy with epirubicin, cisplatin, 5-fluorouracil (ECF regimen), and Chloroxoquinoline in patients with metastatic gastric cancer. "
2.	Breast Neoplasms (Breast Cancer) 12/25/2019 - "Chloroxoquinoline inhibits the cytoskeleton in breast cancer Bcap37 and MDA-MB-453 cells and inhibits cell migration. " 12/25/2019 - "Breast cancer Bcap37 and MDA-MB-453 cells were treated with different concentrations of chloroxoquinoline. " 12/25/2019 - "To investigate the effect of chloroxoquinoline on cytoskeleton of breast cancer cells and its relation with Rho/Rho kinase signaling pathway. " 12/25/2019 - "[Chloroxoquinoline inhibits invasion in breast cancer via down-regulating Rho/Rho kinase signaling pathway]."
3.	Adenocarcinoma 03/01/2009 - "Twenty-two patients with histologically confirmed metastatic gastric adenocarcinoma were treated with a combination of epirubicin 50 mg/m2 (day 1), cisplatin 60 mg/m2 (day 1), 5-fluorouracil 500 mg/m2 (days 1 to 5), and Chloroxoquinoline 400 mg (days 1 to 21), with the cycle repeated every three weeks. "

1.	Combination Drug Therapy (Combination Chemotherapy)
2.	FPEPIR regimen